JM, W., NN, S., & WA, H. (2024). Ablative treatments for locally advanced pancreatic cancer: The CROSSFIRE trial. The lancet. Gastroenterology & hepatology, 9(8), 687. https://doi.org/10.1016/S2468-1253(24)00130-4
Chicago Style (17th ed.) CitationJM, Westerhoff, Sanford NN, and Hall WA. "Ablative Treatments for Locally Advanced Pancreatic Cancer: The CROSSFIRE Trial." The Lancet. Gastroenterology & Hepatology 9, no. 8 (2024): 687. https://doi.org/10.1016/S2468-1253(24)00130-4.
MLA (9th ed.) CitationJM, Westerhoff, et al. "Ablative Treatments for Locally Advanced Pancreatic Cancer: The CROSSFIRE Trial." The Lancet. Gastroenterology & Hepatology, vol. 9, no. 8, 2024, p. 687, https://doi.org/10.1016/S2468-1253(24)00130-4.
Warning: These citations may not always be 100% accurate.